Literature DB >> 11240267

Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression.

Y Herouy1, P Mellios, E Bandemir, S Dichmann, P Nockowski, E Schöpf, J Norgauer.   

Abstract

Stasis dermatitis is a common disorder, which is a consequence of impaired venous drainage of the legs. It is characterized histologically by proliferation of small blood vessels in the papillary dermis. This neovascularization may lead occasionally to the formation of discrete papules due to inflammatory processes. In order to evaluate the role of matrix metalloproteinases (MMPs) in the acute phase of chronic venous insufficiency, we examined the production of MMP-1, -2, -13 and tissue inhibitors of metalloproteinase (TIMP)-1 and -2 in lesional skin of stasis dermatitis. A total of 19 patients affected by stasis dermatitis were included in this experimental study. Polymerase chain reaction, western blot and immunohistochemical studies on tissue specimen were performed. In lesional skin of stasis dermatitis, there was elevated gene expression and immunoreactivity for MMP-1, -2 and -13 in comparison to healthy controls. In contrast, genexpression and immunoreactivity for TIMP-1 and -2 were diminished in stasis dermatitis in comparison with healthy controls. Overexpression and production of MMP-1, -2 and -13 without inhibitory effects could be the result of cytokine mediated induction. Matrix metalloproteinases (MMPs) may play an important role in the remodeling of lesional skin in stasis dermatitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240267     DOI: 10.1016/s0923-1811(00)00128-6

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  14 in total

Review 1.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

2.  Integrated micro/messenger RNA regulatory networks in essential thrombocytosis.

Authors:  Lu Zhao; Song Wu; Erya Huang; Dimitri Gnatenko; Wadie F Bahou; Wei Zhu
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

3.  Activation of the Wnt/β-catenin pathway and tissue inhibitor of metalloprotease 1 during tertiary dentinogenesis.

Authors:  Seisuke Yoshioka; Yusuke Takahashi; Makoto Abe; Ikumi Michikami; Satoshi Imazato; Satoshi Wakisaka; Mikako Hayashi; Shigeyuki Ebisu
Journal:  J Biochem       Date:  2012-10-04       Impact factor: 3.387

Review 4.  The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis.

Authors:  Paolo Zamboni
Journal:  J R Soc Med       Date:  2006-11       Impact factor: 18.000

5.  Oral doxycycline with topical tacrolimus for treatment of stasis dermatitis due to chronic venous insufficiency: A pilot study.

Authors:  Niteeka Maroo; Supriyo Choudhury; Sumit Sen; Suparna Chatterjee
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

6.  Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa.

Authors:  Sachiko Mori; Ruby Pawankar; Chika Ozu; Manabu Nonaka; Toshiaki Yagi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-12       Impact factor: 5.764

7.  Topical apigenin alleviates cutaneous inflammation in murine models.

Authors:  Mao-Qiang Man; Melanie Hupe; Richard Sun; George Man; Theodora M Mauro; Peter M Elias
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-19       Impact factor: 2.629

8.  The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells.

Authors:  Beatriz Martínez-Poveda; Javier A García-Vilas; Casimiro Cárdenas; Esther Melgarejo; Ana R Quesada; Miguel A Medina
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

9.  Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro.

Authors:  K Asano; A Furuta; K Kanai; S Sakaue; H Suzaki; T Hisamitsu
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

10.  Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Yasuhiro Shibuya; Hiroaki Nakajima; Ken-ichi Kanai; Naohiro Yamada; Harumi Suzaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.